The neuropathology of schizophrenia. A critical review of the data and their interpretation

Brain

Volumn 122, Issue 4, 1999, Pages 593-624

  Harrison, Paul J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Cytoarchitecture; Morphometry; Psychosis; Synapse

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; SEROTONIN;

ALZHEIMER DISEASE; BRAIN ASYMMETRY; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN SCINTISCANNING; BRAIN SIZE; BRAIN VENTRICLE DILATATION; COGNITIVE DEFECT; DENDRITE; ENTORHINAL CORTEX; GLIOSIS; HETEROTOPIA; HIPPOCAMPUS; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; META ANALYSIS; MOLECULAR GENETICS; MORPHOMETRICS; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE FIBER; NEUROPATHOLOGY; NEUROPIL; PHENOTYPE; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPSE; TEMPORAL LOBE; THALAMUS NUCLEUS; ULTRASTRUCTURE;

BRAIN; HUMANS; SCHIZOPHRENIA; SYNAPSES;

EID: 0032924127     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.4.593     Document Type: Review

References (431)

1. Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. [Review]. J Neuropsychiatry Clin Neurosci 1997; 9: 1-17.
2. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998; 155: 761-7.
3. Adams CE, DeMasters BK, Freedman R. Regional zinc staining in postmortem hippocampus from schizophrenic patients. Schizophr Res 1995; 18: 71-7.
4. Aganova EA, Uranova NA. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol 1992; 22: 59-65.
5. Ajtai BM, Kallai L, Kalman M. Capability for reactive gliosis develops prenatally in the diencephalon but not in the cortex of rats. Exp Neurol 1997; 146: 151-8.
6. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA, et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993a; 50: 169-77.
7. Akbarian S, Viñuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993b; 50: 178-87.
8. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A. Bunney WE Jr, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics [see comments]. Arch Gen Psychiatry 1995; 52: 258-66.
9. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996; 53: 425-36.
10. Akil M, Lewis DA. Cytoarchitecture of the entorhinal cortex in schizophrenia. Am J Psychiatry 1997; 154: 1010-2.
11. Allendoerfer KL, Shatz CJ. The subplate, a transient neocortical structure: its role in the development of connections between thalamus and cortex. [Review]. Annu Rev Neurosci 1994; 17: 185-218.
12. Altshuler LL, Conrad A, Kovelman JA, Scheibel A. Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection. Arch Gen Psychiatry 1987; 44: 1094-8.
13. Altshuler LL. Casanova MF, Goldberg TE, Kleinman JE. The hippocampus and parahippocampus in schizophrenia, suicide, and control brains [published erratum appears in Arch Gen Psychiatry 1991; 48; 442] . Arch Gen Psychiatry 1990; 47: 1029-34.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV. 4th ed. Washington (DC): American Psychiatric Association; 1994.
15. Anderson B, Rutledge V. Age and hemisphere effects on dendritic structure. Brain 1996; 119: 1983-90.
16. Anderson SA, Volk DW, Lewis DA. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 1996; 19: 111-9.
17. Andrade JP, Castanheira-Vale AJ, Paz-Dias PG, Madeira MD, Paula-Barbosa MM. The dendritic trees of neurons from the hippocampal formation of protein-deprived adult rats. A quantitative Golgi study. Exp Brain Res 1996: 109: 419-33.
18. Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. [Review]. Lancet 1995; 346: 477-81.
19. Andreasen NC, Arndt S, Swayze V 2nd, Cizadlo T. Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging [see comments]. Science 1994: 266: 294-8. Comment in: Science 1994; 266: 221.
20. Andreasen NC, Arndt S, Swayze V 2nd, Cizadlo T. Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging [see comments]. Science 1994: 266: 294-8. Comment in: Science 1994; 266: 221.
21. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, et al. Schizophrenia and cognitive dysmetria: a positronemission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 1996: 93: 9985-90.
22. Anezaki T, Yanagisawa K. Takahashi H, Nakajima T, Miyashita K, Ishikawa A, et al. Remote astrocytic response of prefrontal cortex is caused by the lesions in the nucleus basalis of Meynert, but not in the ventral tegmental area. Brain Res 1992; 574: 63-9.
23. Aquino DA, Padin C, Perez JM, Peng D, Lyman WD, Chiu FC. Analysis of glial fibrillary acidic protein, neurofilament protein, actin and heat shock proteins in human fetal brain during the second trimester. Brain Res Dev Brain Res 1996; 91: 1-10.
24. Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol (Berl) 1983; 61: 101-8.
25. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropȧthology of schizophrenia. [Review]. Acta Neuropathol (Berl) 1996; 92: 217-31.
26. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991a; 48: 625-32.
27. Arnold SE, Lee VM-Y, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991b; 88: 10850-4.
28. Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995a; 152: 738-48.
29. Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, et al. Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. Am J Psychiatry 1995b; 152: 731-7.
30. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol (Berl) 1996; 91: 269-77.
31. Arnold SE, Ruscheinsky DD, Han LY. Further evidence of abnormal cytoarchilecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 1997a; 42: 639-47.
32. Arnold SE, Joo E, Martinoli MG, Roy N, Trojanowski JQ, Gur RE, et al. Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features [see comments]. Neuroreport 1997b; 8: 1523-6.
33. Comment in: Neuroreport 1997; 8: i-ii.
34. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry 1998; 55: 225-32.
35. 2A receptors and clozapine response. Schizophr Res 1998; 32: 93-9.
36. Averback P. Lesions of the nucleus ansae peduncularis in neuropsychiatric disease. Arch Neurol 1981; 38: 230-5.
37. Bailey A, Luthert P, Dean A. Harding B, Janota I, Montgomery M, et al. A clinicopathological study of autism. Brain 1998; 121: 889-905.
38. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia [published erratum appears in Neuroreport 1997; 154: 1180]. Neuroreport 1997; 154: 861-3.
39. Barta PE. Pearlson GD, Powers RE. Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990; 147: 1457-62.
40. Barta PE, Pearlson GD, Brill LB 2nd, Royall R, McGilchrist IK, Pulver AE, et al. Planum temporale asymmetry reversal in schizophrenia: replication and relationship to gray matter abnormalities. Am J Psychiatry 1997; 154: 661-7.
41. Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and cortical gyral patterns. Brain 1997; 120: 257-69.
42. Beall MJ, Lewis DA. Heterogeneity of layer II neurons in human entorhinal cortex. J Comp Neurol 1992; 321: 241-66.
43. Beasley CL, Reynolds GP. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 1997; 24: 349-55.
44. Beauregard M, Malkova L, Bachevalier J. Stereotypies and loss of social affiliation after early hippocampectomy in primates. Neuroreport 1995; 6: 2521-6.
45. Beckmann H, Lauer M. The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics. Psychiatry Res 1997; 68: 99-109.
46. Belichenko PV, Hagberg B, Dahlström A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol (Berl) 1997; 93: 50-61.
47. Benes FM. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. [Review]. Schizophr Bull 1998; 24: 219-30.
48. Benes FM, Bird ED. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 1987; 44: 608-16.
49. Benes FM, Davidson J. Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 1986; 43: 31-5.
50. Benes FM, Majocha RE, Bird ED, Marotta CA. Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry 1987; 44: 1017-21.
51. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991a; 48: 996-1001.
52. Benes FM, Sorensen I, Bird ED. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991b; 17: 597-608.
53. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 1992a; 2: 503-12.
54. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992b; 12: 924-9.
55. Benes FM, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 1994; 51: 477-84.
56. Benes FM, Todtenkopf MS, Taylor JB. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 1997; 25: 80-92.
57. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998; 44: 88-97.
58. Benowitz LI, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. [Review]. Trends Neurosci 1997; 20: 84-91.
59. Berman NE, Raymond LA, Warren KA, Raghavan R, Joag SV, Narayan O, et al. Fractionator analysis shows loss of neurons in the lateral geniculate nucleus of macaques infected with neurovirulent simian immunodeficiency virus. Neuropathol Appl Neurobiol 1998; 24: 44-52.
60. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867-75.
61. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153: 1554-63.
62. Bertolino A, Callicott JH. Elman I, Mattay VS, Tedeschi G, Frank JA, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998; 43: 641-8.
63. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992; 18: 437-48.
64. Bilder RM, Wu H, Bogerts B, Degreef G, Ashtari M, Alvir JM, et al. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 1994; 151: 1437-47.
65. Bilder RM, Bogerts B, Ashtari M, Wu H, Alvir JM, Jody D, et al. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res 1995; 17: 47-58.
66. Blanchard JJ, Neale JM. The neuropsychological signature of schizophrenia: generalized or differential deficit? Am J Psychiatry 1994; 151: 40-8.
67. Blennow K, Davidsson P, Gottfries C-G, Ekman R, Heilig M. Synaptic degeneration in thalamus in schizophrenia [letter]. Lancet 1996; 348: 692-3.
68. Bleuler E. Dementia praecox or the group of schizophrenias 1911. Transl. J. Zinkin. New York: International Universities Press; 1950.
69. Bloom FE. Advancing a neurodevelopmental origin for schizophrenia. [Review]. Arch Gen Psychiatry 1993; 50: 224-7.
70. Bogerts B, Häntsch J, Herzer M. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry 1983; 18: 951-69.
71. Bogerts B, Meertz E, Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. Arch Gen Psychiatry 1985; 42: 784-91.
72. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 19990a; 35: 1-13.
73. Bogerts B, Falkai P, Haupts M, Greve B, Ernst S, Tapernon-Franz U, et al. Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res 1990b; 3: 295-301.
74. Braak H, Braak E. Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Prog Brain Res 1986; 70: 185-212.
75. Bracha HS. Etiology of structural asymmetry in schizophrenia: an alternative hypothesis [letter]. Schizophr Bull 1991; 17: 551-3.
76. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997; 94: 2569-74.
77. Briess D, Cotter D, Doshi R, Everall I. Mammillary body abnormalities in schizophrenia [letter]. Lancet 1998; 352: 789-90.
78. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502-8.
79. Brown R, Colter N, Corsellis JA, Crow TJ, Frith CD, Jagoe R, et al. Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry 1986; 43: 36-42.
80. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993; 34: 529-35.
81. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG, Roberts GW. Schizophrenia and the brain: a prospective cliniconeuropathological study. Psychol Med 1990; 20: 285-304.
82. Bruton CJ, Stevens JR, Frith CD. Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations. Neurology 1994; 44: 34-42.
83. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, et al. Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993; 150: 59-65.
84. Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, et al. PET and MR1 of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996; 153: 191-9.
85. Buckley PF. The clinical stigmata of aberrant neurodevelopment in schizophrenia. [Review]. J Nerv Ment Dis 1998; 186: 79-86.
86. Buhl L, Bojsen-Møller M. Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan Med Bull 1988; 35: 288-90.
87. Bullmore ET, Woodruff PW, Wright IC, Rabe-Hesketh S, Howard RJ, Shuriquie N, et al. Does dysplasia cause anatomical dysconnectivity in schizophrenia? Schizophr Res 1998; 30: 127-35.
88. 2A receptor mRNA in human brain. Brain Res 1995; 676: 157-68.
89. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 1996; 15: 442-55.
90. 3H]S-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 1997; 30: 565-74.
91. Cannon M, Jones P. Schizophrenia. [Review]. J Neurol Neurosurg Psychiatry 1996; 60: 604-13.
92. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors [see comments]. Arch Gen Psychiatry 1993; 50: 551-64. Comment in: Arch Gen Psychiatry 1995; 52: 157-9.
93. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors [see comments]. Arch Gen Psychiatry 1993; 50: 551-64. Comment in: Arch Gen Psychiatry 1995; 52: 157-9.
94. Carlsson M, Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? [Review]. Schizophr Bull 1990; 16: 425-32.
95. Casanova MF, Zito M, Bigelow LB, Berthot B, Sanders RD, Kleinman JE. Axonal counts of the corpus callosum of schizophrenic patients. J Neuropsychiatry Clin Neurosci 1989; 1: 391-3.
96. Casanova MF, Stevens JR, Kleinman JE. Astrocytosis in the molecular layer of the dentate gyms: a study in Alzheimer's disease and schizophrenia. Psychiatry Res 1990; 35: 149-66.
97. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-6.
98. Crichton-Browne J. On the weight of the brain and its component parts in the insane. Brain 1879; 2: 42-67.
99. Christensen E, Moller JE, Faurbye A. Neuropathological investigation of 28 brains from patients with dyskinesia. Acta Psychiatr Scand 1910; 46: 14-23.
100. Christison GW, Casanova MF, Weinberger DR. Rawlings R, Kleinman JE. A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry 1989; 46: 1027-32.
101. Chua SE, McKenna PJ. Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. [Review], Br J Psychiatry 1995; 166: 563-82.
102. Cohen JD, Servan-Schreiber D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. [Review]. Psychol Rev 1992; 99: 45-77.
103. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991: 48: 413-7.
104. Corsellis JAN. Mental illness and the ageing brain. Institute of Psychiatry Maudsley Monographs No. 9. London: Oxford University Press; 1962.
105. Corsellis JAN. Psychoses of obscure pathology. In: Blackwood W, Corsellis JAN, editors. Greenfield's neuropathology. 3rd ed. London: Edward Arnold; 1976, p. 903-15.
106. Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP. Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 1997; 765: 238-46.
107. Crow TJ. Molecular pathology of schizophrenia: more than one disease process? [Review], Br Med J 1980; 280: 66-8.
108. Crow TJ. Temporal lobe asymmetries as the key to the etiology of schizophrenia. [Review]. Schizophr Bull 1990; 16: 433-43.
109. Crow TJ. Schizophrenia as failure of hemispheric dominance for language [see comments]. [Review]. Trends Neurosci 1997; 20: 339-43. Comment in: Trends Neurosci 1998; 21: 145-7.
110. Crow TJ. Schizophrenia as failure of hemispheric dominance for language [see comments]. [Review]. Trends Neurosci 1997; 20: 339-43. Comment in: Trends Neurosci 1998; 21: 145-7.
111. Crow TJ. Schizophrenia as a transcallosal misconnection syndrome. Schizophr Res 1998; 30: 111-4.
112. Crow TJ, Ball J, Bloom SR, Brown R, Bruton CJ, Colter N, et al. Schizophrenia as an anomaly of development of cerebral asymmetry. Arch Gen Psychiatry 1989; 46: 1145-50.
113. da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitkovic L. Gliosis in human brain: relationship to size but not other properties of astrocytes. Brain Res 1993; 600: 161-5.
114. Daniel DG, Goldberg TE. Gibbons RD, Weinberger DR. Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls. Biol Psychiatry 1991; 30: 887-903.
115. Danos P, Baumann B, Bernstein H-G, Franz M, Stauch R, Northoff G, et al. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res 1998; 82: 1-10.
116. David GB. The pathological anatomy of the schizophrenias. In: Richter D, editor. Schizophrenia: somatic aspects. London: Pergamon Press; 1957, p. 93-130.
117. David AS, Cutting JC. The neuropsychology of schizophrenia. Hove (UK): Lawrence Erlbaum; 1994.
118. Davidson M, Keefe RS. Cognitive impairment as a target for pharmacological treatment in schizophrenia. [Review]. Schizophr Res 1995; 17: 123-9.
119. Davidson L. McGlashan TH. The varied outcomes of schizophrenia [review]. Can J Psychiatry 1997; 42: 34-43.
120. Davidson M, Harvey P, Welsh KA, Powchik P, Putnam KM, Mohs RC. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Am J Psychiatry 1996; 153: 1274-9.
121. Davis KL, Kahn RS, KoG, Davidson M. Dopamine in schizophrenia: a review and reconceptualization [see comments]. Am J Psychiatry 1991; 148: 1474-86. Comment in. Am J Psychiatry 1992; 149: 1284-5. Comment in: Am J Psychiatry 1992; 149: 1620-1.
122. Davis KL, Kahn RS, KoG, Davidson M. Dopamine in schizophrenia: a review and reconceptualization [see comments]. Am J Psychiatry 1991; 148: 1474-86. Comment in. Am J Psychiatry 1992; 149: 1284-5. Comment in: Am J Psychiatry 1992; 149: 1620-1.
123. Davis KL, Kahn RS, KoG, Davidson M. Dopamine in schizophrenia: a review and reconceptualization [see comments]. Am J Psychiatry 1991; 148: 1474-86. Comment in. Am J Psychiatry 1992; 149: 1284-5. Comment in: Am J Psychiatry 1992; 149: 1620-1.
124. Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, et al. Ventricular enlargement in poor-outcome schizophrenia [see comments]. Biol Psychiatry 1998; 43: 783-93. Comment in: Biol Psychiatry 1998; 43: 781-2.
125. Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, et al. Ventricular enlargement in poor-outcome schizophrenia [see comments]. Biol Psychiatry 1998; 43: 783-93. Comment in: Biol Psychiatry 1998; 43: 781-2.
126. Davison K. Schizophrenia-like psychoses associated with organic cerebral disorders: a review. [Review], Psychiatr Dev 1983; 1: 1-33.
127. Daviss SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 1995; 59: 81-96.
128. de Brabander JM, Kramers RJK. Uylings HBM. Layer-specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex. Eur J Neurosci 1998; 10: 1261-9.
129. De Lacoste M-C, White CL, 3d. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system [see comments]. [Review]. Neurobiol Aging 1993; 14: 1-16.
130. Comment in: Neurobiol Aging 1993; 14: 49-50, Comment in: Neurobiol Aging 1993; 14: 51-4; disc 55-6.
131. Comment in: Neurobiol Aging 1993; 14: 49-50, Comment in: Neurobiol Aging 1993; 14: 51-4; disc 55-6.
132. Comment in: Neurobiol Aging 1993; 14: 49-50, Comment in: Neurobiol Aging 1993; 14: 51-4; disc 55-6.
133. Deakin JF, Simpson MD. A two-process theory of schizophrenia: evidence from studies in post-mortem brain. [Review]. J Psychiat Res 1997:31: 277-95.
134. Degreef G, Ashtari M. Bogerts B. Bilder RM. Jody DN, Alvir JM, et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry 1992; 49: 531-7.
135. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997; 154: 688-90.
136. Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry' 1998; 43: 483-8.
137. DeLisi LE. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? [Review]. Schizophr Res 1997; 23: 119-29.
138. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL. Crimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997a: 74: 129-40.
139. DeLisi LE, Sakuma M, Kushner M, Finer DL. Hoff AL, Crow TJ. Anomalous cerebral asymmetry and language processing in schizophrenia [published erratum appears in Schizophr Bull 1997; 23: 536]. Schizophr Bull 1997b; 23: 255-71.
140. Dell'Anna ME, Geloso MC, Draisci G, Luthman J. Transient changes in fos and GFAP immunoreactivity precede neuronal loss in the rat hippocampus following neonatal anoxia. Exp Neurol 1995; 131: 144-56.
141. Doody GA, Johnstone EC, Sanderson TL, Owens DGC, Muir WJ. 'Pfropfschizophrenie' revisited: schizophrenia in people with mild learning disability. Br J Psychiatry 1998; 173: 145-53.
142. Drevets WC, Ongur D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 1998; 3: 220-6.
143. Dwork AJ. Postmortem studies of the hippocampal formation in schizophrenia. [Review]. Schizophr Bull 1997; 23: 385-402.
144. Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69: 339-43.
145. Eastwood SL, Harrison PJ. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience 1998; 86: 437-48.
146. Eastwood SL, Burnet PWJ, McDonald B, Clinton J, Harrison PJ. Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience 1994a; 59: 881-92.
147. Eastwood SL, Burnet PW, Harrison PJ. Striatal synaptophysin expression and haloperidol-induced synaptic plasticity. Neuroreport 1994b; 5: 677-80.
148. Eastwood SL, Burnet PW, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995a; 66: 309-19.
149. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GIuRl and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 1995b; 29: 211-23.
150. Eastwood SL, Heffernan J, Harrison PJ. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol Psychiatry 1997a; 2: 322-9.
151. Eastwood SL, Kerwin RW, Harrison PJ. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry 1997b; 41: 636-43.
152. Elliott R, Sahakian, BJ. The neuropsychology of schizophrenia: relations with clinical and neurobiological dimensions. [Review]. Psychol Med 1995; 25: 581-94.
153. Elston GN, Rosa MG. Morphological variation of layer III pyramidal neurones in the occipitotemporal pathway of the macaque monkey visual cortex. Cereb Cortex 1998; 8: 278-94.
154. Falkai P, Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 1986; 236: 154-61.
155. Falkai P, Bogerts B. Cytoarchitectonic and developmental studies in schizophrenia. In: Kerwin RW, editor. Neurobiology and psychiatry. Vol. 2. Cambridge: Cambridge University Press; 1993. p. 43-70.
156. Falkai P, Bogerts B, Rozumek M. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study. Biol Psychiatry 1988; 24: 515-21.
157. Falkai P, Bogerts B, Greve B, Pfeiffer U, Machus B, Fölsch-Reetz B, et al. Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res 1992; 7: 23-32.
158. Falkai P, Bogerts B, Schneider T, Greve B, Pfeiffer U, Pilz K, et al. Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res 1995; 14: 161-76.
159. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982; 17: 319-34.
160. Fisman M. The brain stem in psychosis. Br J Psychiatry 1975; 126: 414-22.
161. Flaum M, Arndt S, Andreasen NC. The role of gender in studies of ventricle enlargement in schizophrenia: a predominantly male effect [see commentsl. Am J Psychiatry 1990; 147: 1327-32. Comment in: Am J Psychiatry 1991; 148: 1754-6.
162. Flaum M, Arndt S, Andreasen NC. The role of gender in studies of ventricle enlargement in schizophrenia: a predominantly male effect [see commentsl. Am J Psychiatry 1990; 147: 1327-32. Comment in: Am J Psychiatry 1991; 148: 1754-6.
163. Flaum M, Swayze VW 2nd, O'Leary DS, Yuh WT, Ehrhardt JC, Arndt SV, et al. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am J Psychiatry 1995; 152: 704-14.
164. Flor-Henry P. Psychosis and temporal lobe epilepsy. A controlled investigation. Epilepsia 1969; 10: 363-95.
165. Frazier JA, Giedd JN, Hamburger SD, Albus KE, Kaysen D, Vaituzis AC, et al. Brain anatomic magnetic resonance imaging in childhoodonset schizophrenia. Arch Gen Psychiatry 1996; 53: 617-24.
166. Friede RL. Developmental neuropathology. Berlin: Springer Verlag; 1989.
167. Fristen KJ. The disconnection hypothesis. Schizophr Res 1998; 30: 115-25.
168. Friston KJ, Frith CD. Schizophrenia: a disconnection syndrome? [Review]. Clin Neurosci 1995; 3: 89-97.
169. Frith CD, Friston KJ, Herold S, Silbersweig D, Fletcher P, Cahill C, et al. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry 1995; 167: 343-9.
170. Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies R, et al. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia [published erratum appears in Arch Gen Psychiatry 1997; 54: 912]. 559-66.
171. Galaburda AM. Anatomic basis for cerebral dominance. In: Richardson RE, Hugdahl K, editors. Cerebral asymmetry. Boston: MIT Press; 1994. p. 51-73.
172. Garcia-Rill E. Biedermann JA, Chambers T, Skinner RD, Mrak RE, Husain M, et al. Mesopontine neurons in schizophrenia. Neuroscience 1995; 66: 321-35.
173. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65: 446-53.
174. Carver DL. The etiologic heterogeneity of schizophrenia. Harvard Rev Psychiatry 1997; 4: 317-27.
175. Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry 1995; 167: 786-93.
176. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity [corrected and republished article originally appeared in Arch Gen Psychiatry 1997; 54: 660-9]. Arch Gen Psychiatry 1997; 54: 943-52.
177. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. [Review], Schizophr Bull 1993; 19: 797-804.
178. Goldsmith SK, Joyce JN. Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry 1995; 37: 122-6.
179. Goodman R. Neuronal misconnections and psychiatric disorder. Is there a link? [see comments]. [Review]. Br J Psychiatry 1989; 154: 292-9. Comment in: Br J Psychiatry 1989; 155: 129-30.
180. Goodman R. Neuronal misconnections and psychiatric disorder. Is there a link? [see comments]. [Review]. Br J Psychiatry 1989; 154: 292-9. Comment in: Br J Psychiatry 1989; 155: 129-30.
181. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? [see comments], [Review], Am J Psychiatry 1996; 153: 321-30. Comment in: Am J Psychiatry 1997; [54: 443-4.
182. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? [see comments], [Review], Am J Psychiatry 1996; 153: 321-30. Comment in: Am J Psychiatry 1997; [54: 443-4.
183. Guillery RW, Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissues [comment]. J Comp Neurol 1997; 386: 2-7. Comment on: J Comp Neurol 1996; 364: 6-15.
184. Guillery RW, Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissues [comment]. J Comp Neurol 1997; 386: 2-7. Comment on: J Comp Neurol 1996; 364: 6-15.
185. Gur RE, Mozley PD, Shtasel DL, Cannon TD, Gallacher F, Turetsky B, et al. Clinical subtypes of schizophrenia: differences in brain and CSF volume [see comments]. Am J Psychiatry 1994; 151: 343-50. Comment in: Am J Psychiatry 1995; 152: 817-8.
186. Gur RE, Mozley PD, Shtasel DL, Cannon TD, Gallacher F, Turetsky B, et al. Clinical subtypes of schizophrenia: differences in brain and CSF volume [see comments]. Am J Psychiatry 1994; 151: 343-50. Comment in: Am J Psychiatry 1995; 152: 817-8.
187. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, et al. A follow-up magnetic resonance imaging study of schizophrenia. Arch Gen Psychiatry 1998; 55: 145-52.
188. 3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Arch Gen Psychiatry 1997; 54: 225-32.
189. Hafner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Loffler W, et al. Causes and consequences of the gender difference in age at onset of schizophrenia. [Review]. Schizophr Bull 1998; 24: 99-113.
190. Halliday GM, Cullen KM, Kril JJ, Harding AJ, Harasty J. Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: a quantitative study using different antisera. Neurosci Lett 1996; 209: 29-32.
191. Haracz JL. Neural plasticity in schizophrenia. Schizophr Bull 1985; 11: 191-229.
192. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, et al. Cortical cholinergic markers in schizophrenia. Schizophr Res 1994; 12: 137-44.
193. Harrison PJ. Effects of neuroleptics on neuronal and synaptic structure. In: Barnes TRE, editor Antipsychotic drugs and their side-effects. London: Academic Press; 1993. p. 99-110.
194. Harrison PJ. Advances in post-mortem molecular neurochemistry and neuropathology: examples from schizophrenia research. [Review]. Br Med Bull 1996; 52: 527-38.
195. Harrison PJ. Schizophrenia: a disorder of neurodevelopment? [Review]. Curr Opin Neurobiol 1997a; 7: 285-9.
196. Harrison PJ. Schizophrenia and its dementia. In: Esiri MM, Morris JH, editors. The neuropathology of dementia. Cambridge: Cambridge University Press; 1997b. p. 385-97.
197. Harrison PJ. Brains at risk of schizophrenia [Editorial]. Lancet 1999a; 353: 3-4.
198. 2A receptors. Br J Psychiatry 1999b; 174 Suppl 38: 41-51.
199. 2A) receptor gene in the aetiology, pathophysiology and pharmacotherapy of schizophrenia. J Psychopharmacol (Oxf) 1997; 11: 18-20.
200. Harrison PJ, Eastwood SL. Preferential involvement of excitatory neurons in the medial temporal lobe in schizophrenia. Lancet 1998; 352: 1669-73.
201. Haug JO. Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatr Scand 1982; 66: 374-83.
202. Hayes TL, Lewis DA. Magnopyramidal neurons in the anterior motor speech region. Dendritic features and interhemispheric comparisons. Arch Neurol 1996; 53: 1277-83.
203. Heckers S. Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. [Review], Schizophr Bull 1997; 23: 403-21.
204. Heckers S, Heinsen H, Heinsen YC, Beckmann H. Limbic structures and lateral ventricle in schizophrenia: a quantitative postmortem study [see comments]. Arch Gen Psychiatry 1990; 47: 1016-22. Comment in: Arch Gen Psychiatry 1991; 48: 956-8.
205. Heckers S, Heinsen H, Heinsen YC, Beckmann H. Limbic structures and lateral ventricle in schizophrenia: a quantitative postmortem study [see comments]. Arch Gen Psychiatry 1990; 47: 1016-22. Comment in: Arch Gen Psychiatry 1991; 48: 956-8.
206. Heckers S, Heinsen H, Heinsen Y, Beckmann H. Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry 1991a; 29: 556-66.
207. Heckers S, Heinsen H, Geiger B, Beckmann H. Hippocampal neuron number in schizophrenia: a stereological study. Arch Gen Psychiatry 1991b; 48: 1002-8.
208. Heffernan JM, Eastwood SL, Nagy Z, Sanders MW, McDonald B, Harrison PJ. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Exp Neurol 1998; 150: 235-9.
209. Heinsen H, Gössmann E, Rüb U, Eisenmenger W, Bauer M, Ulmar G, et al. Variability in the human entorhinal region may confound neuropsychiatrie diagnoses. Acta Anat (Basel) 1996; 157: 226-37.
210. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Cooper SJ, Herron BM et al. Anomalies of cerebral asymmetry in schizophrenia interact with gender and age of onset: a post-mortem study. Schizophr Res 1998; 34: 13-25.
211. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 1999; 122:99-110.
212. Hill C, Keks N, Roberts S, Opeskin K, Dean B, MacKinnon A, et al. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153: 533-7.
213. Ho K-C, Gwozdz JT, Hause LL, Antuono PG. Correlation of neuronal cell body size in motor cortex and hippocampus with body height, body weight, and axonal length. Int J Neurosci 1992; 65: 147-53.
214. Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992; 149: 898-903.
215. Hoffman RE, Dobscha SK. Cortical pruning and the development of schizophrenia: a computer model [see comments], Schizophr Bull 1989; 15: 477-90. Comment in: Schizophr Bull 1990; 16: 567-70.
216. Hoffman RE, Dobscha SK. Cortical pruning and the development of schizophrenia: a computer model [see comments], Schizophr Bull 1989; 15: 477-90. Comment in: Schizophr Bull 1990; 16: 567-70.
217. Honer WG, Bassett AS, Smith GN, Lapointe JS, Falkai P. Temporal lobe abnormalities in multigenerational families with schizophrenia. Biol Psychiatry 1994; 36: 737-43.
218. Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997; 78: 99-110.
219. Horton K, Forsyth CS, Sibtain N, Ball S, Bruton CJ, Royston MC, et al. Ubiquitination as a probe for neurodegeneration in the brain in schizophrenia: the prefrontal cortex. Psychiatry Res 1993; 48: 145-52.
220. Howard CV, Reed MG. Unbiased stereology. Oxford: Bios; 1998.
221. Huber G, The heterogeneous course of schizophrenia. Schizophr Res 1997; 28: 177-85.
222. Huttenlocher PR. Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Res 1979; 163: 195-205.
223. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis [see comments]. Arch Neurol 1992; 49: 401-6. Comment in: Arch Neurol 1993; 50: 131.
224. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis [see comments]. Arch Neurol 1992; 49: 401-6. Comment in: Arch Neurol 1993; 50: 131.
225. Insausti R, Tuñón T. Sobreviela T, Insausti AM, Gonzalo LM. The human entorhinal cortex: a cytoarchitectonic analysis. J Comp Neurol 1995; 355: 171-98.
226. Jablensky A. Schizophrenia: recent epidemiologic issues. [Review]. Epidemiol Rev 1995; 17: 10-20.
227. Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S, et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998; 155: 678-85.
228. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 1998; 95: 735-40.
229. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986; 65: 303-26.
230. Jakob H, Beckmann H. Gross and histological criteria for developmental disorders in brains of schizophrenics. [Review]. J R Soc Med 1989; 82: 466-9.
231. Jaskiw GE, Juliano DM, Goldberg TE, Hertzman M, Urow-Hamell E, Weinberger DR. Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study. Schizophr Res 1994; 14: 23-8.
232. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia [see comments]. [Review]. Am J Psychiatry 1991; 148: 1301-8. Comment in: Am J Psychiatry 1992; 149: 848-9.
233. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia [see comments]. [Review]. Am J Psychiatry 1991; 148: 1301-8. Comment in: Am J Psychiatry 1992; 149: 848-9.
234. Jellinger K. Neuropathologic findings after neuroleptic long-term therapy. In: Roizin L, Shiraki H, Grcevic N, editors. Neurotoxicology. New York: Raven Press; 1977. p. 25-42.
235. Jellinger K. Neuromorphological background of pathochemical studies in major psychoses. In: Beckmann H, Riederer P, editors. Pathochemical markers in major psychoses. Berlin: Springer; 1985. p. 1-23.
236. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry 1989; 46: 1019-24.
237. Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR [published erratum appears in J Neurosci Methods 1998; 79: 233], J Neurosci Methods 1997; 77: 83-92.
238. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924-6.
239. Johnstone EC, McMillan JF, Crow TJ. The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Psychol Med 1987; 17: 371-9.
240. Johnstone EC, Bruton CJ, Crow TJ, Frith CD, Owens DG. Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment. J Neurol Neurosurg Psychiatry 1994; 57: 474-9.
241. Jones EG. Cortical development and thalamic pathology in schizophrenia [see comments]. [Review). Schizophr Bull 1997a; 23: 483-501. Comment in: Schizophr Bull 1997; 23: 509-12. Comment in: Schizophr Bull 1997; 537-40.
242. Jones EG. Cortical development and thalamic pathology in schizophrenia [see comments]. [Review). Schizophr Bull 1997a; 23: 483-501. Comment in: Schizophr Bull 1997; 23: 509-12. Comment in: Schizophr Bull 1997; 537-40.
243. Jones EG. Cortical development and thalamic pathology in schizophrenia [see comments]. [Review). Schizophr Bull 1997a; 23: 483-501. Comment in: Schizophr Bull 1997; 23: 509-12. Comment in: Schizophr Bull 1997; 537-40.
244. Jones P. The early origins of schizophrenia. [Review]. Br Med Bull 1997b; 53: 135-55.
245. Jones TA, Schauert T. Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci 1994; 14: 2140-52.
246. Jønsson SA, Luts A, Guldberg-Kjaer N, Brun A. Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia. Eur Arch Psychiatry Clin Neurosci 1997; 247: 120-7.
247. 2 receptors to neuronal circuits in human brain: insights into schizophrenia. [Review]. Neuropsychopharmacology 1997; 16: 375-84.
248. Kalman M, Csillag A, Schleicher A, Rind C, Hajós F, Zilles K. Long-term effects of anterograde degeneration on astroglial reaction in the rat geniculo-cortical system as revealed by computerized image analysis. Anat Embryol (Berl) 1993; 187: 1-7.
249. Kalus P, Senitz D, Beckmann H. Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res 1997; 75: 49-59.
250. Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. [Review]. Am J Psychiatry 1996; 153: 466-76.
251. Katsetos CD, Hyde TM, Herman MM. Neuropathology of the cerebellum in schizophrenia - an update: 1996 and future directions. [Review]. Biol Psychiatry 1997; 42: 213-24.
252. Katz M, Buchsbaum MS, Siagel BV Jr, Wu J, Haier RJ, Bunney WE Jr Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 1996; 33: 1-11.
253. Kegeles LS, Humaran J, Mann JJ, In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry 1998; 44: 382-98.
254. Kelley JJ, Gao XM, Tamminga CA, Roberts RC. The effect of chronic haloperidol treatment on dendritic spines in the rat striatum. Exp Neurol 1997; 146: 471-8.
255. Kennedy JL. Schizophrenia genetics: the quest for an anchor [editorial]. Am J Psychiatry 1996; 153: 1513-4.
256. Kenny JT, Friedman L, Findling RL, Swales TP, Strauss ME, Jesberger JA, et al. Cognitive impairment in adolescents with schizophrenia. Am J Psychiatry 1997; 154: 1613-5.
257. Kerwin R, Patel S, Meldrum B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post-mortem. Neuroscience 1990; 39: 25-32.
258. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. [Review]. J Psychiatr Res 1994a; 28: 239-65.
259. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment [letter]. Lancet 1994b; 344: 1434.
260. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 1998; 155: 774-8.
261. Kleinman JE, Hyde TM, Herman MM. Methodological issues in the neuropathology of mental illness. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology. The fourth generation of progress. New York: Raven Press; 1995. p. 859-64.
262. KoIb B, Whishaw IQ. Brain plasticity and behavior. [Review]. Annu Rev Psychol 1998; 49: 43-64.
263. Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry 1984; 19: 1601-21.
264. Kreutzberg GW, Blakemore WF, Graeber MB. Cellular pathology of the central nervous system. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Edward Arnold; 1997. p. 85-156.
265. Krimer LS, Herman MM, Saunders RC, Boyd JC, Hyde TM, Carter JM, et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 1997a; 7: 732-9.
266. Krimer LS, Hyde TM, Herman MM, Saunders RC. The entorhinal cortex: an examination of cyto-and myeloarchitectonic organization in humans. Cereb Cortex 1997b; 7: 722-31.
267. Kulynych JJ, Vladar K, Jones DW, Weinberger DR. Superior temporal gyrus volume in schizophrenia: a study using MRI morphometry assisted by surface rendering. Am J Psychiatry 1996; 153: 50-6.
268. Kung L, Conley R, Chute DJ, Smialek J, Roberts RC. Synaptic changes in the striatum of schizophrenic cases: a controlled postmortem ultrastructural study. Synapse 1998; 28: 125-39.
269. Kwon JS, Shenton ME, Hirayasu Y, Salisbury DF, Fischer IA, Dickey CC, et al. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry 1998; 155: 509-15.
270. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93: 9235-40.
271. Lauriello J, Hoff A, Wieneke MH, Blankfeld H, Faustman WO, Rosenbloom M, et al. Similar extent of brain dysmorphology in severely ill women and men with schizophrenia. Am J Psychiatry 1997; 154: 819-25.
272. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. [Review]. Br J Psychiatry 1998; 172: 110-20.
273. Lawrie SM, Whalley H, Kestelman JN, Abukmeil SS, Byne M, Hodges A, et al. Magnetic resonance imaging of the brain in subjects at high risk of developing schizophrenia. Lancet 1999; 353: 30-3.
274. Lewis DA. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. [Review]. Neuropsychopharmacology 1997; 16: 385-98.
275. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992; 160: 179-86.
276. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. [Review]. Neuropsychopharmacology 1997; 17: 205-29.
277. Lim KO, Tew W, Kushner M, Chow K, Matsumoto B, DeLisi LE. Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry 1996; 153: 1548-53.
278. Lipska BK, Weinberger DR. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA 1995; 92: 8906-10.
279. Lohr JB, Jeste DV. Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 1988; 77: 689-97.
280. Madsen AL, Keiding N. Karle A. Esbjerg S, Hemmingsen R. Neuroleptics in progressive structural brain abnormalities in psychiatric illness [letter]. Lancet 1998; 352: 784-5.
281. Maier M. Ron MA, Barker GJ, Tofts PS. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia [published erratum appears in Psychol Med 1996; 26: 877]. Psychol Med 1995; 25: 1201-9.
282. Marsh L, Suddath RL, Higgins N, Weinberger DR. Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness. Schizophr Res 1994; 11: 225-38.
283. Marsh L, Harris D, Lim KO, Beal M, Hoff AL, Minn K, et al. Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset. Arch Gen Psychiatry 1997; 54: 1104-12.
284. Masliah E, Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. [Review]. Brain Pathol 1993; 3: 77-85.
285. Masliah E. Mallory M, Hansen L, DeTeresa R, Terry RD. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993; 43: 192-7.
286. Mayhew TM, Gundersen HJ. 'If you assume, you can make an ass out of u and me': a decade of the disector for stereological counting of particles in 3D space. [Review]. J Anat 1996; 188: 1-15.
287. McGuffin P, Owen MJ, Farmer AE. Genetic basis of schizophrenia. Lancet 1995; 346: 678-82.
288. McGuire PK, Frith CD. Disordered functional connectivity in schizophrenia [editorial]. Psychol Med 1996; 26: 663-7.
289. McKenna PJ. Schizophrenia and related syndromes. Oxford: Oxford University Press: 1994.
290. McKenna PJ, Tamlyn D, Lund CE. Mortimer AM, Hammond S, Baddeley AD. Amnesic syndrome in schizophrenia. Psychol Med 1990; 20: 967-72.
291. Meltzer HY. Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review. [Review], Br J Psychiatry 1996; 168 Suppl 29: 23-31.
292. Mesulam M-M. Schizophrenia and the brain [editorial; comment). N Engl J Med 1990; 322: 842-5. Comment on: N Engl J Med 1990; 322: 789-94.
293. Mesulam M-M. Schizophrenia and the brain [editorial; comment). N Engl J Med 1990; 322: 842-5. Comment on: N Engl J Med 1990; 322: 789-94.
294. Mesulam M-M, Geschwind N. On the possible role of neocortex and its limbic connections in the process of attention and schizophrenia: clinical cases of inattention in man and experimental anatomy in monkey. J Psychiatr Res 1978; 14: 249-59.
295. Miyakawa T, Sumiyoshi S, Deshimaru M, Suzuki T, Tomonari H. Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathol (Berl) 1972; 20: 67-77.
296. Miyake T, Kitamura T, Takamatsu T, Fujita S. A quantitative analysis of human astrocytosis. Acta Neuropathol (Berl) 1988; 75: 535-7.
297. Moser M-B, Trommald M, Andersen P. An increase in dendritic spine density on hippocampal CA1 pyramidal cells following spatial learning in adult rats suggests the formation of new synapses. Proc Natl Acad Sci USA 1994; 91: 12673-5.
298. Murphy GM Jr, Lim KO, Wieneke M, Ellis WG, Forno LS, Hoff AL, et al. No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol Psychiatry 1998; 43: 205-9.
299. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? [editorial] Br Med J 1987; 295: 681-2.
300. Murray RM, Woodruff PWR. Developmental insanity or dementia praecox: a new perspective on an old debate. Neurol Psychiatry Brain Res 1995; 3: 167-76.
301. Murray RM, O'Callaghan E, Castle DJ, Lewis SW. A neuro-developmental approach to the classification of schizophrenia. [Review]. Schizophr Bull 1992; 18: 319-32.
302. Nair TR, Christensen JD. Kingsbury SJ, Kumar NG, Terry WM. Garver DL. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res 1997; 74: 141-50.
303. Nasrallah HA, McCalley-Whitters M, Bigelow LB, Rauscher FP. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Res 1983; 8: 251-60.
304. Nelson MD, Saykin AJ. Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998; 55: 433-40.
305. Nieto D, Escobar A. Major psychoses. In: Minckler J, editor. Pathology of the nervous system. New York: McGraw-Hill; 1972. p. 2655-65.
306. Niizato K, Arai T, Kuroki N, Kase K. Iritani S, Ikeda K. Autopsy study of Alzheimer's disease brain pathology in schizophrenia. Schizophr Res 1998; 31: 177-84.
307. Noga JT, Bartley AJ, Jones DW, Torrey EF, Weinberger DR. Conical gyral anatomy and gross brain dimensions in monozygotic twins discordant for schizophrenia. Schizophr Res 1996; 22: 27-40.
308. Nopoulos P, Flaum M, Andreasen NC. Sex differences in brain morphology in schizophrenia [see comments]. 48-54. Comment in: Am J Psychiatry 1997; 154: 1637-9.
309. Nopoulos P, Flaum M, Andreasen NC. Sex differences in brain morphology in schizophrenia [see comments]. 48-54. Comment in: Am J Psychiatry 1997; 154: 1637-9.
310. 11C]N-methylspiperone [see comments]. Psychiatry Res 1995; 61: 67-83. Comment in: Psychiatry Res 1996; 67: 159-62.
311. 11C]N-methylspiperone [see comments]. Psychiatry Res 1995; 61: 67-83. Comment in: Psychiatry Res 1996; 67: 159-62.
312. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET [see comments]. Nature 1997; 385: 634-6. Comment in: Nature 1997; 385: 578-9.
313. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET [see comments]. Nature 1997; 385: 634-6. Comment in: Nature 1997; 385: 578-9.
314. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia [see comments]. Arch Gen Psychiatry 1995; 52: 998-1007. Comment in: Arch Gen Psychiatry 1997; 54: 578-80.
315. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia [see comments]. Arch Gen Psychiatry 1995; 52: 998-1007. Comment in: Arch Gen Psychiatry 1997; 54: 578-80.
316. Ong WY, Garey LJ. Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophr Res 1993; 10: 15-27.
317. Owen F, Simpson MDC. The neurochemistry of schizophrenia. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. Oxford: Blackwell Science; 1995. p. 358-78.
318. Pakkenberg B. Post-mortem study of chronic schizophrenic brains. BrJ Psychiatry 1987; 151: 744-52.
319. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47: 1023-8.
320. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res 1992; 7: 95-100.
321. Pakkenberg B. Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus. Neuropathol Appl Neurobiol 1993a; 19: 373-80.
322. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry 1993b; 34: 768-72.
323. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997; 120: 1823-43.
324. Pearlson GD, Petty RG, Ross CA, Tien AY. Schizophrenia: a disease of heteromodal association cortex. [Review]. Neuropsychopharmacology 1996; 14: 1-17.
325. Pearlson GD, Barta PE. Powers RE, Menon RR, Richards SS, Aylward EH. et al. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 1997; 41: 1-14.
326. Pearson RCA, Powell TPS. The neuroanatomy of Alzheimer's disease. Rev Neurosci 1989; 2: 101-22.
327. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 1996; 93: 14182-7.
328. Pierce JP, Lewin GR. An ultrastructural size principle. [Review]. Neuroscience 1994; 58: 441-6.
329. Plum F. Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. Neurosci Res Program Bull 1972; 10: 384-8.
330. Portas CM, Goldstein JM, Shenton ME, Hokama HH, Wible CG, Fischer I, et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998; 43: 649-59.
331. Porter RH, Eastwood SL, Harrison PJ. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 1997; 751: 217-31.
332. Powchik P, Friedman J, Haroutunian V, Greenberg D, Allsteil L, Purohit D, et al. Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 1997; 42: 296-8.
333. Prohovnik I, Dwork AJ, Kaufman MA, Willson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 1993; 19: 805-16.
334. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davies KL. Alxheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry 1998; 55: 205-11.
335. Raedler TJ, Knable MB, Weinberger DR. Schizophrenia as a developmental disorder of the cerebral cortex. [Review]. Curr Opin Neurobiol 1998; 8: 157-61.
336. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998; 55: 215-24.
337. Randall PL. Schizophrenia, abnormal connection, and brain evolution. Med Hypotheses 1983; 10: 247-80.
338. Rapoport JL, Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, et al. Childhood-onset schizophrenia. Progressive ventricular change during adolescence [see comments]. Arch Gen Psychiatry 1997; 54: 897-903. Comment in: Arch Gen Psychiatry 1997; 54: 913-4.
339. Rapoport JL, Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, et al. Childhood-onset schizophrenia. Progressive ventricular change during adolescence [see comments]. Arch Gen Psychiatry 1997; 54: 897-903. Comment in: Arch Gen Psychiatry 1997; 54: 913-4.
340. Raymond GV, Bauman ML, Kemper TL. Hippocampus in autism: a Golgi analysis. Acta Neuropathol (Berl) 1996; 91: 117-9.
341. Raz S, Raz N. Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. Psychol Bull 1990; 108: 93-108.
342. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry [995; 152: 444-6.
343. Reveley AM, Reveley MA, Clifford CA, Murray RM. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982; 1: 540-1.
344. Reyes MG, Gordon A. Cerebellar vermis in schizophrenia [letter]. Lancet 1981; 2, 700-1.
345. Reynolds GP. Neurotransmitter systems in schizophrenia. [Review]. Int Rev Neurobiol 1995; 38: 305-39.
346. Reynolds GP. Dopamine D4 receptors in schizophrenia [letter; comment]. J Neurochem 1996; 66: 881-3. Comment on: J Neurochem 1995; 64: 1413-5.
347. Reynolds GP. Dopamine D4 receptors in schizophrenia [letter; comment]. J Neurochem 1996; 66: 881-3. Comment on: J Neurochem 1995; 64: 1413-5.
348. Riederer P, Gsell W, Calza L, Franzek E, Jungkunz G, Jellinger K, et al. Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post-mortem research. [Review]. J Neural Transm Gen Sect 1995; 102: 255-64.
349. Roberts GW. Schizophrenia: a neuropathological perspective. [Review]. Br J Psychiatry 1991; 158: 8-17.
350. Roberts GW, Colter N, Lofthouse R, Bogerts B, Zech M, Crow TJ. Gliosis in schizophrenia: a survey. Biol Psychiatry 1986; 21: 1043-50.
351. Roberts GW, Colter N, Lofthouse R, Johnstone EC, Crow TJ. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol Psychiatry 1987; 22: 1459-68.
352. Roberts RC, Conley R, Rung L, Peretti FJ, Chute DJ. Reduced striatal spine size in schizophrenia: a postmortem ultrastructural study. Neuroreport 1996; 7: 1214-8.
353. Roberts GW, Royston MC, Weinberger DR. Schizophrenia. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Edward Arnold; 1997. p. 897-929.
354. Roessmann U, Garabetti P. Pathological reaction of astrocytes in perinatal brain injury. Immunohistochemical study. Acta Neuropathol (Berl) 1986; 70: 302-7.
355. Rojiani AM, Emery JA, Anderson KJ, Massey JK. Distribution of heterotopic neurons in normal hemispheric white matter: a morphometric analysis. J Neuropathol Exp Neurol 1996; 55: 178-83.
356. Ron MA, Harvey I. The brain in schizophrenia [see comments]. [Review]. J Neurol Neurosurg Psychiatry 1990; 53: 725-6. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 522, Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 981.
357. Ron MA, Harvey I. The brain in schizophrenia [see comments]. [Review]. J Neurol Neurosurg Psychiatry 1990; 53: 725-6. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 522, Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 981.
358. Ron MA, Harvey I. The brain in schizophrenia [see comments]. [Review]. J Neurol Neurosurg Psychiatry 1990; 53: 725-6. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 522, Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 981.
359. Rosenthal R, Bigelow LB. Quantitative brain measurements in chronic schizophrenia. Br J Psychiatry 1972; 121: 259-64.
360. Russell AJ, Munro JC, Jones PB, Hemsley DR, Murray RM. Schizophrenia and the myth of intellectual decline. Am J Psychiatry 1997; 154: 635-9.
361. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997; 349: 1735-9.
362. Saito S, Kobayashi S, Ohashi Y, Igarashi M, Komiya Y, Ando S. Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents. J Neurosci Res 1994; 39: 57-62.
363. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR, Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 1998; 393: 169-71.
364. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, et al. Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry 1991; 48: 618-24.
365. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994; 51: 124-31.
366. Schlaug G, Armstrong E, Schleicher A, Zilles K. Layer V pyramidal cells in the adult human cingulate cortex. A quantitative Golgistudy. Anat Embryol (Berl) 1993; 187: 515-22.
367. Sedvall G, Farde L. Chemical brain anatomy in schizophrenia [see comments]. [Review]. Lancet 1995; 346: 743-9. Comment in: Lancet 1995; 346: 1302-3.
368. Sedvall G, Farde L. Chemical brain anatomy in schizophrenia [see comments]. [Review]. Lancet 1995; 346: 743-9. Comment in: Lancet 1995; 346: 1302-3.
369. Seeman P, Guan H-C, Van Tol HH. Dopamine D4 receptors elevated in schizophrenia [see comments]. Nature 1993; 365: 441-5. Comment in: Nature 1993; 365: 393.
370. Seeman P, Guan H-C, Van Tol HH. Dopamine D4 receptors elevated in schizophrenia [see comments]. Nature 1993; 365: 441-5. Comment in: Nature 1993; 365: 393.
371. 4 receptors. [Review], Neuropsychopharmacology 1997; 16: 93-110.
372. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995; 52: 805-18.
373. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol 1998; 392: 402-12.
374. Shapiro RM. Regional neuropathology in schizophrenia: where are we? Where are we going? [Review]. Schizophr Res 1993; 10: 187-239.
375. Sharma T, Lancaster E, Lee D, Lewis S, Sigmundsson T, Takei N, et al. Brain changes in schizophrenia. Br J Psychiatry 1998; 173: 132-8.
376. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med 1992; 327: 604-12.
377. Shihabuddin L, Buchsbaum MS, Hazlett EA, Haznedar MM, Harvey PD, Newman A, et al. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry 1998; 55: 235-43.
378. Shioiri T, Oshitani Y, Kato T, Murashita J, Hamakawa H, Inubushi T, et al. Prevalence of cavum septum pellucidum detected by MRI in patients with bipolar disorder, major depression and schizophrenia. Psychol Med 1996; 26: 431-4.
379. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995; 378: 176-9.
380. Silver-man JM, Smith CJ, Guo SL, Mohs RC, Siever LJ, Davis KL. Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders. Biol Psychiatry 1998; 43: 97-106.
381. Simpson MD, Slater P, Deakin JF, Royston MC, Skan WJ. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 1989; 107: 211-5.
382. Soustek Z. Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl Allg Pathol 1989; 135: 25-32.
383. Southard EE. On the topographical distribution of cortex lesions and anomalies in dementia praecox, with some account of their functional significance. Am J Insan 1915; 71: 603-71.
384. Stevens JR. An anatomy of schizophrenia? Arch Gen Psychiatry 1973; 29: 177-89.
385. Stevens JR. Neuropathology of schizophrenia. Arch Gen Psychiatry 1982; 39: 1131-9.
386. Stevens JR. Abnormal reinnervation as a basis for schizophrenia: a hypothesis [published erratum appears in Arch Gen Psychiatry 1992; 49: 708]. [Review]. Arch Gen Psychiatry 1992; 49: 238-43.
387. Stevens JR. Anatomy of schizophrenia revisited. [Review]. Schizophr Bull 1997; 23: 373-83.
388. Stevens J, Casanova M, Bigelow L. Gliosis in schizophrenia [published erratum appears in Biol Psychiatry 1988; 25: 121]. Biol Psychiatry 1988a; 24: 727-9.
389. Stevens CD, Altshuler LL, Bogerts B, Falkai P. Quantitative study of gliosis in schizophrenia and Huntington's chorea. Biol Psychiatry 1988b; 24: 697-700.
390. Stevens JR, Casanova M, Poltorak M, Germain L, Buchan GC. Comparison of immunocytochemical and Holzer's methods for detection of acute and chronic gliosis in human postmortem material [see comments]. J Neuropsychiatry Clin Neurosci 1992; 4: 168-73. Comment in: J Neuropsychiatry Clin Neurosci 1993; 5: 225-7.
391. Stevens JR, Casanova M, Poltorak M, Germain L, Buchan GC. Comparison of immunocytochemical and Holzer's methods for detection of acute and chronic gliosis in human postmortem material [see comments]. J Neuropsychiatry Clin Neurosci 1992; 4: 168-73. Comment in: J Neuropsychiatry Clin Neurosci 1993; 5: 225-7.
392. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia [published erratum appears in N Engl J Med 1990; 322: 1616] [see comments]. N Engl J Med 1990; 322: 789-94. Comment in: N Engl J Med 1990; 322: 842-5, Comment in: N Engl J Med 1990; 323: 545-8.
393. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia [published erratum appears in N Engl J Med 1990; 322: 1616] [see comments]. N Engl J Med 1990; 322: 789-94. Comment in: N Engl J Med 1990; 322: 842-5, Comment in: N Engl J Med 1990; 323: 545-8.
394. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia [published erratum appears in N Engl J Med 1990; 322: 1616] [see comments]. N Engl J Med 1990; 322: 789-94. Comment in: N Engl J Med 1990; 322: 842-5, Comment in: N Engl J Med 1990; 323: 545-8.
395. Tamminga CA. Gender and schizophrenia. [Review]. J Clin Psychiatry 1997; 58 Suppl 15: 33-7.
396. Tamminga CA. Schizophrenia and glutamatergic transmission. [Review]. Crit Rev Neurobiol 1998; 12: 21-36.
397. Tatetsu S. A contribution to the morphological background of schizophrenia: with special reference to the findings in the telencephalon. Acta Neuropathol (Berl) 1964; 3: 558-71.
398. Tcherepanov AA, Sokolov BP. Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. J Neurosci Res 1997; 49: 639-44.
399. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-80.
400. Thibaut F, Coron B, Hannequin D, Segard L, Martin C, Dollfus S, et al. No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients. Schizophr Res 1998; 30: 149-53.
401. Thompson PM, Sower AC, Perrone-Bizzozero NI. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 1998; 43: 239-43.
402. Tononi G, McIntosh AR, Russell DP, Edelman GM. Functional clustering: identifying strongly interactive brain regions in neuroimaging data. Neuroimage 1998; 7: 133-49.
403. Torrey EF, Peterson MR. Schizophrenia and the limbic system. [Review]. Lancet 1974; 2: 942-6.
404. Tran KD, Smutzer GS, Doty RL, Arnold SE. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry 1998; 155: 1288-90.
405. 2A receptor density abnormality in the cortex of schizophrenic patients studied with PET. Schizophr Res 1998; 31: 13-7.
406. Uranova NA, Casanova MF, DeVaughn NM, Orlovskaya DD, Denisov DV. Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients [letter]. Schizophr Res 1996; 22: 81-3.
407. Van Horn JD, McManus IC. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle: brain ratio (VBR) [see comments]. Br J Psychiatry 1992; 160: 687-97. Comment in: Br J Psychiatry 1992; 161: 278, Comment in: Br J Psychiatry 1992; 161: 714-5.
408. Van Horn JD, McManus IC. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle: brain ratio (VBR) [see comments]. Br J Psychiatry 1992; 160: 687-97. Comment in: Br J Psychiatry 1992; 161: 278, Comment in: Br J Psychiatry 1992; 161: 714-5.
409. Van Horn JD, McManus IC. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle: brain ratio (VBR) [see comments]. Br J Psychiatry 1992; 160: 687-97. Comment in: Br J Psychiatry 1992; 161: 278, Comment in: Br J Psychiatry 1992; 161: 714-5.
410. Vaughn JE, Matthews DA, Barber RP, Wimer CC, Wimer RE. Genetically-associated variations in the development of hippocampal pyramidal neurons may produce differences in mossy fiber connectivity. J Comp Neurol 1977; 173: 41-52.
411. Vita A, Dieci M, Giobbio GM, Tenconi F, Invernizzi G. Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. [Review]. Schizophr Res 1997; 23: 25-30.
412. Vogetey K, Hobson T, Schneider-Axmann T, Honer WG, Bogerts B, Falkai P. Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia - a post-mortem study. Schizophr Res 1998; 31: 83-7.
413. Waddington JL, Youssef HA. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med 1996; 26: 681-8.
414. Walker EF, Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol Rev 1997; 104: 667-85.
415. Ward KE, Friedman L, Wise A, Schulz SC. Meta-analysis of brain and cranial size in schizophrenia. Schizophr Res 1996; 22: 197-213.
416. Weickert CS, Weinberger DR. A candidate molecule approach to defining developmental pathology in schizophrenia. [Review]. Schizophr Bull 1998; 24: 303-16.
417. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-9.
418. Weinberger DR. From neuropathology to neurodevelopment. [Review]. Lancet 1995; 346: 552-7.
419. Weinberger DR, Herman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 1992; 149: 890-7.
420. West MJ, Slomianka L. Total number of neurons in the layers of the human entorhinal cortex. Hippocampus 1998; 8: 69-82.
421. Whitworth AB, Honeder M, Kremser C, Kemmler G, Felber S, Hausmann A, et al. Hippocampal volume reduction in male schizophrenic patients. Schizophr Res 1998; 31: 73-81.
422. 2A receptor T102C polymorphism and schizophrenia [letter]. Lancet 1997; 349: 1221.
423. Williams RW, Strom RC, Goldowitz D. Natural variation in neuron number in mice is linked to a major quantitative trait locus on Chr 11. J Neurosci 1998; 18: 138-46.
424. Wisniewski HM, Constantinidis J, Wegiel J, Bobinski M, Tarnawski M. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis Assoc Disord 1994; 8: 211-27.
425. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 5341-6.
426. Woodruff PW, Wright IC, Shuriquie N, Russouw H, Rushe T, Howard RJ, et al. Structural brain abnormalities in male schizophrenics reflect fronto-temporal dissociation. Psychol Med 1997; 27: 1257-66.
427. Young CE, Arima K, Xie J, Hu L, Beach TG, Falkai P, et al. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 1998; 8: 261-8.
428. Zaidel DW, Esiri MM, Harrison PJ. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 1997a; 154: 812-8.
429. Zaidel DW, Esiri MM, Harrison PJ. The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med 1997b; 27: 703-13.
430. 2 receptor densities and the schizophrenic brain. Schizophr Res 1998; 32: 201-6.
431. Zipursky RB, Lambe EK, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry 1998; 55: 540-6.